| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 4e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |